nSTRIDE® APS 自體蛋白抗炎因子注射:針對早期退化性關節炎的安全有效解決方案

nSTRIDE® APS Autologous Protein Anti-Inflammatory Injection: A Safe and Effective Solution for Early Osteoarthritis

Knee pain is a common issue that affects many people, impacting daily life, whether in sports or routine activities. For patients with early osteoarthritis, finding a safe and effective treatment method is crucial. In this regard, nSTRIDE® APS (Autologous Protein Anti-Inflammatory) injection offers an innovative solution that effectively alleviates pain and promotes joint health.

What is nSTRIDE® APS?

nSTRIDE® APS is a small injection designed specifically to relieve knee pain. This treatment method works by injecting high concentrations of beneficial proteins extracted from your own blood into the inflamed knee, counteracting the harmful proteins that cause arthritis. These beneficial proteins not only reduce inflammation but also improve the health of the cartilage.

Treatment Process

The treatment process for nSTRIDE® is relatively simple and quick:

  1. Blood Draw: A small amount of blood is drawn from your arm.
  2. Processing: Within the next hour, the blood undergoes multiple steps to extract anti-inflammatory proteins.
  3. Injection: The processed proteins are injected into the knee joint, helping to alleviate pain, increase mobility, and improve joint function.

Unlike traditional surgery, nSTRIDE® is a rapid procedure, and patients can usually go home within an hour, with minimal recovery time.

Key Benefits of nSTRIDE®

  1. Single Injection

nSTRIDE® is the only single-injection therapy that can provide benefits lasting up to 3 years. This means patients do not need frequent treatments, reducing both time and financial investment.

  1. Autologous Solution

nSTRIDE® uses the patient’s own blood, significantly lowering the risk of allergic reactions and complications. Since it employs only autologous components, safety is assured.

  1. Clinically Proven Effectiveness

Clinical studies indicate that the effects of a single injection can last 24 to 36 months, significantly reducing pain and stiffness while helping to restore mobility. These studies provide a solid scientific foundation for the effectiveness of nSTRIDE®.

  1. High Safety Profile

The safety of nSTRIDE® is widely recognized, as it uses only the patient’s own components, meaning the risk of infection and adverse reactions is very low. Many patients report experiencing mild discomfort after treatment, which typically resolves quickly.

Suitable Candidates

nSTRIDE® is suitable for patients with knee pain due to osteoarthritis. If other early intervention therapies and conservative treatments have not been effective, you may be a candidate for nSTRIDE® treatment. Your doctor will provide recommendations based on your specific situation to help you decide if this therapy is right for you.

Conclusion

For patients with early osteoarthritis, nSTRIDE® Autologous Protein Anti-Inflammatory injection offers a safe and effective treatment option. This therapy not only significantly alleviates pain but also promotes the self-repair of joints, helping patients regain mobility.

If you are interested in learning more about nSTRIDE® treatment, please contact us to schedule a consultation. We will provide the best treatment recommendations based on your specific circumstances, helping you regain health and enjoy a better quality of life.

 

Back to blog

Leave a comment